Olanzapine 2.5 MG

DRUG3 trials

Sponsors

Centre for Addiction and Mental Health, Qinghai Red Cross Hospital, Mahidol University

Conditions

Advanced CancerAnorexiaCachexiaHealthy ControlsOlanzapineProgression Free Survival

Phase 1

Intranasal Insulin and Olanzapine Study in Healthy Volunteers

Centre for Addiction and Mental HealthHealthy Controls

Start: 2019-10-22End: 2024-07-30Target: 64Updated: 2023-07-17

Phase 3

Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer

RecruitingNCT06338683

Qinghai Red Cross HospitalAdvanced Cancer, Olanzapine, Progression Free Survival

Start: 2024-03-20End: 2028-03-20Target: 230Updated: 2024-03-29

Olanzapine for Cancer Related Anorexia-cachexia Syndrome

RecruitingNCT06517199

Mahidol UniversityAnorexia, Cachexia

Start: 2024-01-22End: 2026-01-21Target: 138Updated: 2024-07-24

Related Papers

Investigating the effects of antipsychotics on brain insulin action: Study protocol for a multi-modality magnetic resonance imaging (MRI) study in healthy controls

PLoS ONE2022-11-282 citations